Journal article
FANCM c.5791C > T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor
Paolo Peterlongo, Irene Catucci, Mara Colombo, Laura Caleca, Eliseos Mucaki, Massimo Bogliolo, Maria Marin, Francesca Damiola, Loris Bernard, Valeria Pensotti, Sara Volorio, Valentina Dall'Olio, Alfons Meindl, Claus Bartram, Christian Sutter, Harald Surowy, Valerie Sornin, Marie-Gabrielle Dondon, Severine Eon-Marchais, Dominique Stoppa-Lyonnet Show all
Human Molecular Genetics | OXFORD UNIV PRESS | Published : 2015
DOI: 10.1093/hmg/ddv251
Grants
Awarded by Associazione Italiana per la Ricerca sul Cancro
Awarded by National Institutes of Health (NIH)
Awarded by Spanish Network on Rare Diseases (CIBERER)
Awarded by Spanish Carlos III Health Institute (FIS)
Awarded by Autonomous Government of Catalonia
Awarded by MINECO
Awarded by Generalitat de Catalunya
Awarded by Natural Sciences and Engineering Research Council of Canada (NSERC)
Awarded by NATIONAL CANCER INSTITUTE
Awarded by National Breast Cancer Foundation
Funding Acknowledgements
This study was partially supported by funds from 'Ricerca Finalizzata - Bando 2010' from Ministero della Salute, Italy, to P.P. and C.T., Associazione Italiana per la Ricerca sul Cancro (AIRC-IG 12821) to P.P., (IG 12780) to L.O., (IG 5706) to L.V., and ("5xmille" n. 12237) to A.F., Italian citizens who allocated a 5/1000 share of their tax payment in support of the Fondazione IRCCS Istituto Nazionale Tumori to S.M. and P.R., of the CRO Aviano National Cancer Institute to A.V. and of the Istituto Oncologico Veneto IOV - IRCCS to M.M., according to Italian law and Fondazione Italiana per la Ricerca sul Cancro' (FIRC)-triennial fellowship 'Armanda e Enrivo Mirto' to I.C. and triennial fellowship 'Mario e Valeria Rindi' to V.S.; National Institutes of Health (NIH, CA128978, CA116167 and CA176785) and the Breast Cancer Research Foundation to F.J.C.; Spanish Network on Rare Diseases (CIBERER) and the PI12/00070; the Spanish Carlos III Health Institute (FIS project PI12/02585) to O.D.; Asociacion Espanola Contra el Cancer, Spanish Health Research Foundation, Ramon Areces Foundation, Catalan Health Institute and Autonomous Government of Catalonia (ISCIIIRETIC RD12/0036/008, PI10/01422, PI12/01528, PI13/00285, 2009SGR290 and 2009SGR283); the Swedish Cancer Society, Berta Kamprad Foundation, Gunnar Nilsson Foundation, Bio CARE and the Swedish Society of Medicine; UNI-CANCER, the Ligue Nationale Contre le Cancer and the French National Institute of Cancer (INCa); MINECO (SAF2012-31881), ICREA Academia, Generalitat de Catalunya (SGR0489-2009, SGR317-2014) and European Regional Development FEDER Funds to J.S.; Canadian Breast Cancer Foundation, Canadian Foundation for Innovation, Canada Research Chairs Secretariat and the Natural Sciences and Engineering Research Council of Canada (NSERC Discovery Grant 371758-2009) to P.K.R.